Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor.
Journal: Oncoimmunology
Published: February 21, 2017
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions.
Journal: Cancer immunology research
Published: January 19, 2016
IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 07, 2016
NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines.
Journal: Cancer immunology research
Published: July 09, 2015
Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease.
Journal: Cancer immunology, immunotherapy : CII
Published: February 04, 2014
A phase I trial of bortezomib and interferon-α-2b in metastatic melanoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: December 10, 2013
A naonoporous cell-therapy device with controllable biodegradation for long-term drug release.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 15, 2012
Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulation.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: May 12, 2012
Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
Journal: Surgery
Published: January 06, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026